TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines March 12, 1976
TCL Archive Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget March 20, 1992
TCL Archive Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted September 6, 1974
